Insider Trading April 20, 2026 06:22 PM

FitLife Brands Director Seth Yakatan Adds 164 Shares Under 10b5-1 Plan as Stock Slides

Director's planned purchase worth $2,519 occurs ahead of continuing volatility in the company's share price and mixed fourth-quarter results

By Maya Rios FTLF
FitLife Brands Director Seth Yakatan Adds 164 Shares Under 10b5-1 Plan as Stock Slides
FTLF

Seth Yakatan, a director of FITLIFE BRANDS, INC. (NASDAQ:FTLF), purchased 164 shares on January 15, 2026 under a Rule 10b5-1 trading plan for $2,519. The transaction occurred at a weighted average price of $15.3601 per share. Since the buy, the stock has dropped to $8.99 and the company reported large revenue gains in Q4 2025 alongside pressure on net income and gross margins.

Key Points

  • Director Seth Yakatan purchased 164 shares of FITLIFE BRANDS, INC. (NASDAQ:FTLF) on January 15, 2026 for $2,519 under a Rule 10b5-1 trading plan.
  • The shares were acquired at a weighted average price of $15.3601 per share, with individual prices between $15.29 and $15.75; Yakatan now directly owns 593 shares.
  • FitLife reported a 73% year-over-year revenue increase in Q4 2025 largely due to the Irwin Naturals acquisition, while net income and gross margins declined.

Insider transaction

Seth Yakatan, a director at FITLIFE BRANDS, INC. (NASDAQ:FTLF), completed a purchase of 164 shares of the company's common stock on January 15, 2026. The total consideration for the trade was $2,519.

The shares were purchased at a weighted average price of $15.3601 per share. Individual trades that made up the acquisition ranged between $15.29 and $15.75 per share. The purchase was executed under a Rule 10b5-1 trading plan that Mr. Yakatan had previously adopted. After this transaction Mr. Yakatan directly holds 593 shares of FITLIFE BRANDS, INC. common stock.


Share price context

Since the director's purchase, FITLIFE BRANDS' stock has fallen sharply and is currently trading at $8.99, close to its 52-week low of $8.67. The price movement follows the January transaction and places the current market price substantially below the weighted average at which the director acquired the shares.


Valuation note

According to an InvestingPro analysis referenced in company commentary, FTLF appears undervalued based on its Fair Value assessment and trades at a relatively low earnings multiple, with a reported price-to-earnings (P/E) ratio of 14.6. For investors seeking more detailed research, a comprehensive Pro Research Report on FTLF is available as one of the 1,400+ reports on InvestingPro.


Company financials and disclosures

In related corporate disclosures, FitLife Brands, Inc. reported a 73% year-over-year increase in revenue for the fourth quarter of 2025, a rise the company attributed largely to its acquisition of Irwin Naturals. Despite the substantial revenue growth, the company disclosed declines in net income and in gross margins. FitLife Brands filed an earnings call transcript with the U.S. Securities and Exchange Commission detailing these results for the fiscal year ended December 31, 2025; the transcript was submitted as Exhibit 99.1 in the firm's Form 8-K filing.

These items - the insider purchase under a Rule 10b5-1 plan, the subsequent decline in the company's share price, valuation commentary, and the mixed financial results for the period ending December 31, 2025 - are part of the company's recent public disclosures and strategic developments.

Risks

  • Market risk from a substantial decline in FITLIFE BRANDS' share price - the stock is trading at $8.99, near its 52-week low of $8.67, which could affect investor returns and market perception (equity markets, consumer products sector).
  • Financial performance risk due to declining net income and gross margins despite strong revenue growth, potentially signaling margin pressure after the acquisition (company financials, consumer products sector).
  • Residual execution or disclosure risk tied to the company's strategic actions and public filings, including the Form 8-K submission of the earnings call transcript for the fiscal year ended December 31, 2025 (corporate governance, investors).

More from Insider Trading

KalVista CFO Executes Sell-to-Cover Transaction After RSU Settlement Apr 20, 2026 KalVista CCO Sweeny Sells Shares to Cover RSU Tax Withholding as Ekterly Momentum Persists Apr 20, 2026 Zoom Director Disposes $439,286 in Stock; Trust Holdings Cleared Out Apr 20, 2026 Bicara Therapeutics CEO Disposes $354,145 in Shares, Exercises Options Amid Stock Rally Apr 20, 2026 Broadwood Partners Completes $652,875 Open-Market Purchases in Insight Molecular Diagnostics Apr 20, 2026